Skip to main content
Clinical Trials/NCT05132751
NCT05132751Not yet recruitingNot Applicable

Effect of a Machine Learning Ventilator Decision System Versus Standard Controlled Ventilation on in Critical Care: a Randomized Trial

Hu Anmin0 sites300 target enrollmentStarted: January 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
300
Primary Endpoint
Mechanical ventilation time

Study Overview

Brief Summary

Ventilator-induced lung injury is associated with increased morbidity and mortality. Despite intense efforts in basic and clinical research, an individualized ventilation strategy for critically ill patients remains a major challenge. However, an individualized mechanical ventilation approach remains a challenging task: A multitude of factors, e.g., lab values, vitals, comorbidities, disease progression, and other clinical data must be taken into consideration when choosing a patient's specific optimal ventilation regime. The aim of this work was to evaluate the machine learning ventilator decision system, which is able to suggest a dynamically optimized mechanical ventilation regime for critically-ill patients. Compare with standard controlled ventilation, to test whether the clinical application of the machine learning ventilator decision system reduces mechanical ventilation time and mortality.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • only the first ICU stay was eligible;
  • adults ≥ 18 years of age on ICU admission;
  • estimate mechanical ventilation time ≥24 hours;

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Mechanical ventilation time

Time Frame: through study completion, an average of 5 days

Secondary Outcomes

  • Length of ICU stay time(through study completion, an average of 1 week)
  • Length of hospital stay(through study completion, an average of 2 weeks)
  • In-hospital mortality(through study completion, an average of 2 weeks)

Investigators

Sponsor
Hu Anmin
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Hu Anmin

The Second Clinical Medical College of Jinan University

The Second Clinical Medical College of Jinan University

Similar Trials